Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3,900.00p
   
  • Change Today:
    -50.00p
  • 52 Week High: 4,500.00p
  • 52 Week Low: 3,800.00p
  • Currency: UK Pounds
  • Shares Issued: 5.21m
  • Volume: 12,400
  • Market Cap: £203.16m

Other News

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 3,900.00p
Change Today -50.00p
% Change -1.27 %
52 Week High 4,500.00p
52 Week Low 3,800.00p
Volume 12,400
Shares Issued 5.21m
Market Cap £203.16m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.36% below the market average84.36% below the market average84.36% below the market average84.36% below the market average84.36% below the market average
72.55% below the sector average72.55% below the sector average72.55% below the sector average72.55% below the sector average72.55% below the sector average
Price Trend
67.66% below the market average67.66% below the market average67.66% below the market average67.66% below the market average67.66% below the market average
54.1% below the sector average54.1% below the sector average54.1% below the sector average54.1% below the sector average54.1% below the sector average
Income Not Available
Growth
78.01% above the market average78.01% above the market average78.01% above the market average78.01% above the market average78.01% above the market average
2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average

Bioventix Dividends

  Latest Previous
  1st Interim Special
Ex-Div 08-Apr-21 29-Oct-20
Paid 23-Apr-21 13-Nov-20
Amount 43.00p 53.00p

Trades for 04-Aug-2021

Time Volume / Share Price
16:24 1,000 @ 3,910.00p
12:05 4,470 @ 3,950.00p
12:05 4,470 @ 3,950.00p
16:26 200 @ 3,900.00p
16:26 200 @ 3,900.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page